Richard Baugh
As an alumnus of Pembroke College (Molecular and Cellular Biochemistry, 2013-2017), the college played a significant role in the person and scientist I am today. Having enjoyed 4 tremendous years at Pembroke studying Biochemistry as an undergraduate, I am incredibly excited to return to experience it again (this time from the other side).
I have always had a deep fascination in molecular biochemistry, with a specific focus on understanding how and why various diseases such a cancer occur, and how to develop novel ways of treating them.
Since graduating from Biochemistry, I was awarded a personal studentship from Brain Research UK to study for a DPhil in Oncology in Oxford. Now my research has led me to more of a virology, immunology and oncology focus, as I carry out a research project investigating novel immunotherapies using oncolytic viruses for the treatment of glioblastoma brain tumours.
I am currently a final year DPhil student project in the Anticancer Viruses and Cancer Vaccines Research Group, headed by Professor Len Seymour at the Department of Oncology, University of Oxford. I was awarded funding by Brain Research UK to investigate novel immunotherapies for the treatment of glioblastoma brain tumours. My research seeks to enhance the efficacy of oncolytic Herpes Simplex 1viruses in the context of glioblastoma by activating the immune system.
I originally studied Molecular and Cellular Biochemistry at Pembroke College, graduating in 2017.
Baugh, R.; Khalique, H.; Seymour, L.W. Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers 2020, 12, 3827.
Khalique H, Baugh R, Dyer A, et al Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy Journal for ImmunoTherapy of Cancer 2021;9:e001292.
Richard Baugh
As an alumnus of Pembroke College (Molecular and Cellular Biochemistry, 2013-2017), the college played a significant role in the person and scientist I am today. Having enjoyed 4 tremendous years at Pembroke studying Biochemistry as an undergraduate, I am incredibly excited to return to experience it again (this time from the other side).
I have always had a deep fascination in molecular biochemistry, with a specific focus on understanding how and why various diseases such a cancer occur, and how to develop novel ways of treating them.
Since graduating from Biochemistry, I was awarded a personal studentship from Brain Research UK to study for a DPhil in Oncology in Oxford. Now my research has led me to more of a virology, immunology and oncology focus, as I carry out a research project investigating novel immunotherapies using oncolytic viruses for the treatment of glioblastoma brain tumours.
I am currently a final year DPhil student project in the Anticancer Viruses and Cancer Vaccines Research Group, headed by Professor Len Seymour at the Department of Oncology, University of Oxford. I was awarded funding by Brain Research UK to investigate novel immunotherapies for the treatment of glioblastoma brain tumours. My research seeks to enhance the efficacy of oncolytic Herpes Simplex 1viruses in the context of glioblastoma by activating the immune system.
I originally studied Molecular and Cellular Biochemistry at Pembroke College, graduating in 2017.
Baugh, R.; Khalique, H.; Seymour, L.W. Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers 2020, 12, 3827.
Khalique H, Baugh R, Dyer A, et al Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy Journal for ImmunoTherapy of Cancer 2021;9:e001292.